Soligenix (SNGX) had its "sell (e+)" rating reaffirmed by
Weiss Ratings.
Soligenix (SNGX) Strengthens Pipeline as European Commission Grants SGX945 Orphan Status [Yahoo! Finance]
Soligenix (SNGX) Advances CTCL Research With Interim Analysis, Comparative Study Results [Yahoo! Finance]
Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy [Yahoo! Finance]
Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy [TheStreet.com]